Sentences with phrase «advanced ovarian cancer»

Although the majority of women with advanced ovarian cancer respond to first - line chemotherapy, most responses are not durable.

The program aims to change the way people think about advanced ovarian cancer.

While going through treatment for advanced ovarian cancer in 2006 - 2007, I ate as many green foods as possible, ate limited grains, limited fruits — only berries, not the sweeter fruits and did not eat sugar.

Clovis Oncology shares jumped 15 percent Monday after the FDA approved Rubraca (rucaparib), the company's advanced ovarian cancer drug.

The trial, conducted in advanced ovarian cancer patients, was a pilot trial aimed primarily at determining safety and feasibility, but there were clear signs that it could be effective: About half of the vaccinated patients showed signs of anti-tumor T - cell responses, and those «responders» tended to live much longer without tumor progression than those who didn't respond.

But Shih says there are only a few drug options proven effective for treating advanced ovarian cancer, and that patients might be at risk for different or worse side effects after adding a new drug to their regimen.

Among 10 women with advanced ovarian cancer who got injections of the personalized vaccine once every three weeks — with the medications cyclophosphamide and bevacizumab (marketed as Avastin)-- eight showed a strong immune response and were still alive after two years.

During the arbitration of the Daubert Motion, the arbitrator repeatedly asked defendant's expert to explain the scientific basis for his opinion that the plaintiff had advanced ovarian cancer prior to 1999; the defense expert could not do so and the arbitrator allowed plaintiffs» Daubert motion, thereby excluding his testimony.

When patients with advanced ovarian cancer become resistant to one drug, clinicians usually prescribe a new drug.

Based on results of the current study described in a report online June 18 in the journal Cancer Cell, Johns Hopkins researchers say they are planning a phase I clinical trial to test the paclitaxel - fostamatinib combination therapy in patients with recurrent advanced ovarian cancer.

«Presurgery chemotherapy may make advanced ovarian cancers responsive to immunotherapy.»

Most patients diagnosed with advanced ovarian cancer develop platinum resistant / refractory disease.

«Upfront surgery aiming at macroscopic complete resection is the goal in patients with primary advanced ovarian cancer,» said Philipp Harter, MD, PhD, of the Kliniken Essen - Mitte in Germany, during his presentation of the LION study (abstract 5500) at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.

Plaintiff developed symptoms consistent with cancer, and the defendant diagnosed advanced ovarian cancer which would have been prevented with the treatment the plaintiff had requested.

Subsequent ultrasound revealed advanced ovarian cancer.

DC and NYC About Blog The largest global charitable organization dedicated to advancing ovarian cancer research while supporting women and their families.

There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan.

Diamond is also quick to point out that while the current study shows that COXEN could have been used to predict the most useful drug in many of these cases of advanced ovarian cancer, the actual use of the model will be possible only after validation with a prospective clinical trial.

Surgeons gathered to focus on a quality improvement program to address a central issue in treating advanced ovarian cancer — how to optimize surgery to achieve complete removal of all visible tumor — also called optimal resection.

The drug is meant for women with advanced ovarian cancer who have already been treated with two or more chemotherapies.

Plaintiff deposed defendant's gynecologic pathologist expert over two days during which the expert could not point to a single report in the medical literature to support his belief that the plaintiff already had advanced ovarian cancer prior to her first visit with the defendant.

The poor survival in advanced ovarian cancer is due both to late diagnosis, as well as to the lack of effective second - line therapy for patients who relapse.

«Personalized tumor vaccine shows promise in pilot trial: Vaccine against patients» own tumors triggers a broad response, and induced five - year remission in one patient with advanced ovarian cancer.»

Shares of Clovis Oncology closed up 8.82 percent Monday as the company received early approval for its advanced ovarian cancer drug Rubraca (rucaparib).

Paclitaxel and another chemotherapy drug, carboplatin, are considered standard, first - line treatments for advanced ovarian cancer, experts say, and most patients respond to the drugs initially.

And the study finally showed that patients who had been serendipitously given the drug that the COXEN model would have picked for them lived 21 months longer than the average patient with advanced ovarian cancer.

When COXEN looked back through this registry of advanced ovarian cancer, it first sorted tumors into those that had responded and those that had not responded to each drug («what would have been the right drug in each case»).

Technology developed at Western University and Lawson Health Research Institute can provide a new window into whether or not patients are responding to treatment for advanced ovarian cancer.

«Anderson algorithm increases surgical success with advanced ovarian cancer.»

For advanced ovarian cancer, median survival was 1.3 years for African Americans and 2.3 years for the rest of the participants.

«New mutation linked to ovarian cancer can be passed down through dad: A mutation on the X-chromosome may advance ovarian cancer's age of onset by more than 6 years.»

I incorporate chemotherapy that can be delivered directly into the abdomen for women who have advanced ovarian cancer.

«Our data indicate that systematic LNE of clinical negative lymph nodes in patients with advanced ovarian cancer and complete resection should be omitted,» Harter concluded.

Systematic lymphadenectomy in patients with advanced ovarian cancer and complete resection does not improve progression - free or overall survival, and should be omitted, according to results of a new study.

Systematic lymphadenectomy (LNE) in patients with advanced ovarian cancer and complete resection does not improve progression - free or overall survival (OS), and should be omitted, according to results of a new study.

New Standard of Care A 50 - year - old method for delivering chemotherapy directly into the abdomen was reevaluated for patients with ovarian cancer after a seven - year study of more than 400 patients revealed increased survival rates in patients with advanced ovarian cancer.

«Clinicians will need to make decisions based upon the specific subsets of patients with advanced ovarian cancer, including the stage of the cancer,» added Dr. Ursula Matulonis, director of medical gynecologic oncology at Dana - Farber Cancer Institute and an associate professor of medicine at Harvard Medical School in Boston.

When diagnosed with advanced ovarian cancer, 59 - year - old Barbara Chance, of Glendale, Ariz., was not expecting to later feel numbness and pain in her feet and hands.

com Four years ago, Angie DeWilfond of moline, Illinois, was diagnosed with advanced ovarian cancer.

While I was being treated for advanced ovarian cancer and going for chemotherapy, Gary and I went on our...

I kind of got on the juicing bandwagon because seven years ago, I was diagnosed with advanced ovarian cancer and I realized I needed to cram nutrients.

Dear Friends, In July of 2007, I had my third and last surgery in a ten - month period for advanced ovarian cancer.

When Deane Berg was 49 she was diagnosed with advanced ovarian cancer.